GlycoMimetics Inc (GLYC)
0.2716
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.2711
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Total Return Level: 0.2716 for May 31, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 31, 2024 | 0.2717 |
May 30, 2024 | 0.274 |
May 29, 2024 | 0.2565 |
May 28, 2024 | 0.267 |
May 24, 2024 | 0.27 |
May 23, 2024 | 0.2732 |
May 22, 2024 | 0.2823 |
May 21, 2024 | 0.2754 |
May 20, 2024 | 0.2889 |
May 17, 2024 | 0.2994 |
May 16, 2024 | 0.2811 |
May 15, 2024 | 0.27 |
May 14, 2024 | 0.276 |
May 13, 2024 | 0.2624 |
May 10, 2024 | 0.2666 |
May 09, 2024 | 0.298 |
May 08, 2024 | 0.2984 |
May 07, 2024 | 0.3054 |
May 06, 2024 | 0.3155 |
May 03, 2024 | 1.83 |
May 02, 2024 | 1.72 |
May 01, 2024 | 1.62 |
April 30, 2024 | 1.80 |
April 29, 2024 | 1.55 |
April 26, 2024 | 1.64 |
Date | Value |
---|---|
April 25, 2024 | 1.71 |
April 24, 2024 | 1.855 |
April 23, 2024 | 1.835 |
April 22, 2024 | 1.80 |
April 19, 2024 | 1.925 |
April 18, 2024 | 2.16 |
April 17, 2024 | 2.28 |
April 16, 2024 | 2.15 |
April 15, 2024 | 2.255 |
April 12, 2024 | 2.40 |
April 11, 2024 | 2.505 |
April 10, 2024 | 2.45 |
April 09, 2024 | 2.68 |
April 08, 2024 | 2.59 |
April 05, 2024 | 2.75 |
April 04, 2024 | 2.71 |
April 03, 2024 | 2.765 |
April 02, 2024 | 2.96 |
April 01, 2024 | 3.04 |
March 28, 2024 | 3.00 |
March 27, 2024 | 3.18 |
March 26, 2024 | 2.85 |
March 25, 2024 | 2.82 |
March 22, 2024 | 2.93 |
March 21, 2024 | 2.88 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.2565
Minimum
May 29 2024
12.85
Maximum
Jul 15 2019
2.734
Average
2.28
Median
Mar 31 2020
Total Return Level Benchmarks
Altimmune Inc | 14.13 |
Lyell Immunopharma Inc | 2.77 |
Amicus Therapeutics Inc | 9.80 |
InfuSystems Holdings Inc | 7.14 |
Nanoviricides Inc | 2.40 |